Fundraising FoxSenseonics Holdings
NASDAQ: SENSGermantown, US · Founded 2015 · Delaware corporation · 2 known investors
Find your way into Senseonics Holdings
Sign up to see every warm intro you have to Senseonics Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Senseonics Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Senseonics develops and commercializes Eversense, an implantable continuous glucose monitoring system designed to measure blood sugar levels for up to one year in people with diabetes, offering an alternative to conventional glucose monitors that require more frequent sensor replacement. The company sells its system directly and through distribution partners in the United States and Europe.
Founders & leadership
MJ
Mukul JainExecutive
RS
Rick SullivanExecutiveRick Sullivan is an Executive Officer at Senseonics Holdings, which develops and commercializes Eversense, an implantable continuous glucose monitoring system for diabetes management. He has held finance and accounting leadership roles in both public and private organizations.
KL
Kenneth L HortonExecutive
TT
Timothy T. GoodnowExecutive
MP
Mirasol PanlilioExecutiveMirasol Panlilio is an executive officer at Senseonics Holdings with over 25 years of experience in medical diagnostics, including work in strategic planning, product development, commercialization, and international sales and marketing.
RD
R. Don ElseyExecutive
Board
DA
Douglas A. RoederBoard director
BH
Brian HansenBoard director
AR
Anthony RaabBoard director
MJ
PJ
Investors · 2
New Enterprise Associates (NEA)listed by New Enterprise Associates (NEA)Menlo Park · $200K – $40M
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$39.3M disclosed across 3 of 5 rounds · 2015–2026
▶$20.3MraisedMay 2025 · 1 investors · Other Health CareRule 506(b)
▶$20.3MraisedMay 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen P. DeFalcoDirector
- Sharon LarkinDirector
- Brian HansenDirector
- Douglas S. PrinceDirector
- Timothy T. GoodnowExecutive Officer, Director
- Steven EdelmanDirector
- Douglas A. RoederDirector
- Edward J. FiorentinoDirector
- Rick SullivanExecutive Officer
- Koichiro SatoDirector
- Mukul JainExecutive Officer
- Francine R. KaufmanExecutive Officer, Director
- Kenneth L. HortonExecutive Officer
- Offering amount
- $20.3M
- Amount sold
- $20.3M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16MraisedNov 2024 · 1 investors · BiotechnologyRule 506(b)
▶$16MraisedNov 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen P. DeFalcoDirector
- Steven EdelmanDirector
- Mukul JainExecutive Officer
- Douglas A. RoederDirector
- Sharon S. LarkinDirector
- Douglas PrinceDirector
- Brian HansenDirector
- Francine R. KaufmanExecutive Officer, Director
- Rick SullivanExecutive Officer
- Anthony RaabDirector
- Kenneth L HortonExecutive Officer
- Timothy T. GoodnowExecutive Officer, Director
- Koichiro SatoDirector
- Edward J. FiorentinoDirector
- Offering amount
- $16M
- Amount sold
- $16M
- Sales commissions
- $1M
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedSep 2020 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedSep 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy T. GoodnowExecutive Officer, Director
- Nick TresslerExecutive Officer
- Stephen DeFalcoDirector
- Douglas S. PrinceDirector
- Francine KaufmanExecutive Officer, Director
- Steven V. EdelmanDirector
- Douglas RoederDirector
- Peter Justin KleinDirector
- Edward J. FiorentinoDirector
- Mukul JainExecutive Officer
- Offering amount
- $30M
- Amount sold
- $3M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedDec 2015 · 159 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedDec 2015 · 159 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward J. FiorentinoDirector
- Stephen P. DeFalcoDirector
- Mirasol PanlilioExecutive Officer
- Doug PrinceDirector
- M. James BarrettDirector
- R. Don ElseyExecutive Officer
- Douglas A. RoederDirector
- Timothy T. GoodnowExecutive Officer, Director
- Mukul JainExecutive Officer
- Peter Justin KleinDirector
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
TipRanksFinancial analysis and stock research platform.
DiabetesA nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.
Companies working in the same space as Senseonics Holdings.
Frequently asked questions
- What does Senseonics Holdings do?
- Senseonics develops and commercializes Eversense, an implantable continuous glucose monitoring system designed to measure blood sugar levels for up to one year in people with diabetes, offering an alternative to conventional glucose monitors that require more frequent sensor replacement. The company sells its system directly and through distribution partners in the United States and Europe.
- Who are Senseonics Holdings's investors?
- Senseonics Holdings's investors include New Enterprise Associates (NEA), Vensana Capital.
- How much funding has Senseonics Holdings raised?
- Senseonics Holdings has disclosed $39.3M raised across 3 of its 5 known rounds.
- Where is Senseonics Holdings headquartered?
- Senseonics Holdings is headquartered in Germantown, US.